Gene editing treatment
Pro Research Analysisby 
Searched over 200M research papers
Gene Editing Treatment: Advances, Applications, and Challenges
Introduction to Gene Editing Technologies
Gene editing has revolutionized the field of gene therapy by enabling precise modifications to the human genome. Unlike traditional gene therapy, which involves adding new genes to cells, gene editing allows for the correction of mutations, addition of therapeutic genes, and removal of harmful sequences . The primary tools used in gene editing include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases, and the CRISPR/Cas9 system Maeder2016Li2020.
Applications in Monogenic Disorders
Beta-Thalassemia Treatment
Beta-thalassemia, a hereditary blood disorder characterized by reduced hemoglobin production, has seen significant advancements through gene editing. Traditional treatments like bone marrow transplantation are limited by donor availability and immunological complications. Gene editing tools such as ZFNs, TALENs, and CRISPR/Cas9 have been employed to add or regulate globin genes and repair genetic defects, showing promise in improving patient outcomes Rahimmanesh2022Ernst2020.
Prime Editing for Genetic Diseases
Prime editing, a recent advancement in gene editing, offers the ability to make precise insertions, deletions, and base conversions in the genome. This technology has been explored in preclinical studies for various hereditary diseases, including cystic fibrosis, beta-thalassemia, and X-linked severe combined immunodeficiency. Prime editing holds potential for correcting pathogenic mutations with high accuracy .
Cancer Therapy
Immune Cell Engineering
Gene editing has been pivotal in cancer immunotherapy, particularly in the engineering of T cells. Techniques such as CRISPR/Cas9, TALENs, and ZFNs are used to modify T cells to express chimeric antigen receptors (CARs) targeting cancer cells. This approach has shown remarkable clinical responses in B cell malignancies and is being expanded to other immune cells like natural killer cells and hematopoietic stem cells Ernst2020Bailey2019.
In Vivo Gene Editing
In vivo gene editing has been demonstrated as a feasible approach to target specific mutations in cancer cells. For instance, correcting TERT mutations in glioblastoma has shown potential in reducing tumor growth, providing a platform for direct genetic manipulation in cancer therapy .
Challenges and Future Prospects
Safety and Efficacy Concerns
Despite the promising advancements, gene editing faces several challenges, including off-target effects, DNA-damage toxicity, and immunotoxicity. Ensuring the safety and efficacy of these technologies is crucial for their clinical application. Strategies to improve gene transfer and expression methods are under active investigation Rahimmanesh2022Shim2017.
Regulatory and Ethical Considerations
The clinical implementation of gene editing technologies also raises significant regulatory and ethical issues. The potential for unintended genetic modifications necessitates rigorous safety evaluations and stakeholder education to ensure responsible use of these powerful tools Doudna2020Shim2017.
Conclusion
Gene editing represents a transformative approach in the treatment of genetic diseases and cancer. While significant progress has been made, ongoing research and careful consideration of safety, efficacy, and ethical implications are essential for the successful integration of gene editing into clinical practice. The future of gene editing holds immense potential to cure previously untreatable conditions and improve patient outcomes across a wide range of diseases.
Sources and full results
Most relevant research papers on this topic
Genome-editing Technologies for Gene and Cell Therapy
Genome-editing technologies enable precise manipulation of human genomes for therapeutic effects in gene and cell therapy, offering potential for antiviral strategies, immunotherapies, and treating monogenic hereditary disorders.
Prime Editing for Human Gene Therapy: Where Are We Now?
Prime editing for human gene therapy shows promise in treating inherited diseases by correcting genetic mutations, with potential applications in liver, eye, skin, muscular, and neurodegenerative diseases.
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Genome editing technologies, such as ZFNs, TALENs, and CRISPR/Cas9, show potential for targeted therapy and research in various human diseases, with potential for future clinical trials.
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Gene editing technology shows promise in treating various human diseases, but safety and stakeholder education are crucial for successful implementation in the clinic.
Molecular tumor targeting of gelonin by fusion with F3 peptide
Gene-editing therapies show promise for treating various diseases, but precise engineering and delivery of nucleases pose regulatory challenges and safety concerns.
DOI